Merron 25 Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Cinnarizine

Indications/Uses

Supportive therapy of symptoms of vertigo, dizziness, tinnitus, nystagmus & vomiting; cerebrovascular disturbances including vascular headaches, irritability, memory loss & difficulty in conc.; peripheral circulatory disorders including Reynaud's phenomenon, acrocyanosis, trophic disorders & varicose ulcers, paresthesia, nocturnal cramps & cold extremities. Prophylaxis against travel sickness & migraine.

Dosage/Direction for Use

Cerebral circulatory disorders 75 mg daily. Peripheral circulatory disorders 50-75 mg 3 times daily. Equilibrium disorders 75 mg daily. Max daily dosage: 225 mg. Travel sickness Adult 25 mg 2 hr before traveling & 12.5 mg every 8 hr during the journey. Childn 5-12 yr ½ adult dose.

Administration

Should be taken with food.

Contraindications

Parkinson's disease.

Special Precautions

Co-administration w/ alcohol or CNS depressants. May affect ability to drive or operate machinery. Pregnancy & lactation.

Adverse Reactions

Drowsiness, GI disturbances, extrapyramidal symptoms (mainly in the elderly).

View ADR Monitoring Form

Drug Interactions

Increased sedative effect when co-administered w/ alcohol, CNS depressants or TCA.

MIMS Class

Peripheral Vasodilators & Cerebral Activators / Antivertigo Drugs

ATC Classification

N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.

Regulatory Classification

Presentation/Packing

Form

Merron 25 FC tab 25 mg

Packing/Price

5 × 10's (Rp74,000/boks)

Merron 25

cinnarizine

Manufacturer:

Mersifarma TM